BioCentury
ARTICLE | Clinical News

Safinamide: Phase I; Phase II

July 28, 2003 7:00 AM UTC

Newron said it will start an Austrian Phase I trial in 12 healthy volunteers. Safinamide is in European Phase II trials to treat PD and epilepsy. ...